Inhibrx Biosciences, Inc. (INBX)
(Delayed Data from NSDQ)
$15.20 USD
+0.14 (0.93%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $15.96 +0.76 (5.00%) 7:58 PM ET
3-Hold of 5 3
NA Value
NA Growth NA Momentum NA VGMInhibrx Biosciences, Inc. (INBX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$11.00 | $11.00 | $11.00 | -26.96% |
Price Target
Only one analyst offered a short-term price target of $11.00 for Inhibrx Biosciences, Inc. This represents a decline of 26.96% from the last closing price of $15.06.
Analyst Price Targets (1 )
Broker Rating
Inhibrx Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on only one recommendation.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | NA | NA |
Buy | 0 | 0 | 0 | NA | NA |
Hold | 2 | 2 | 1 | NA | NA |
Sell | 0 | 0 | 0 | NA | NA |
Strong Sell | 0 | 0 | 0 | NA | NA |
ABR | 3.00 | 3.00 | 3.00 | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/23/2024 | JMP Securities | Reni Benjamin | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $11.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | -3.06 |
INBX FAQs
Inhibrx Biosciences, Inc. (INBX) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Inhibrx Biosciences, Inc. (INBX) is $11.00. The current on short-term price targets is based on 1 reports.
The forecasts for Inhibrx Biosciences, Inc. (INBX) range from a low of $11 to a high of $11. The average price target represents a decline of $26.96 from the last closing price of $15.06.
The current DOWNSIDE for Inhibrx Biosciences, Inc. (INBX) is 26.96%
Only one analyst offered a short-term price target of $11.00 for Inhibrx Biosciences, Inc. This represents a decline of 26.96% from the last closing price of $15.06.